Onderzoeker
Sarah-Lee Bekaert
Affiliaties
- Vakgroep Biomoleculaire Geneeskunde (Departement)
Lid
Vanaf17 aug 2020 → Heden
Publicaties
1 - 6 van 6
- Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma(2024)
Auteurs: Stéphane Van Haver, Yujie Fan, Sarah-Lee Bekaert, Celine Everaert, Wouter Van Loocke, Vittorio Zanzani, Joke Deschildre, Ines Fernandez Maestre, Adrianna Amaro, Vanessa Vermeirssen, et al.
- Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN(2024)
Auteurs: Jonatan Linus Gabre, Peter Merseburger, Arne Claeys, Joachim Siaw, Sarah-Lee Bekaert, Franki Speleman, Bengt Hallberg, Ruth H Palmer, Jimmy Van den Eynden
- Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts(2023)
Auteurs: Suzanne Fischer, Elly De Vlieghere, Sarah-Lee Bekaert, An Hendrix, Gwen Sys
- SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry(2023)
Auteurs: Bieke Decaesteker, Amber Louwagie, Fanny De Vloed, Sarah-Lee Bekaert, Suzanne Vanhauwaert, Sara De Brouwer, Ellen Sanders, A Berezovskaya, Geertrui Denecker, Stéphane Van Haver, et al.
- Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma(2023)
Auteurs: Muhammad Rishfi, Simon Krols, Fien Martens, Sarah-Lee Bekaert, Aline Eggermont, Fanny De Vloed, Joshua Robert Goulding, Martijn Risseeuw, Jan Molenaar
- RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition(2022)
Auteurs: Carolina de Carvalho Nunes, Lisa Depestel, Liselot Mus, Kaylee M. Keller, Louis Delhaye, Amber Louwagie, Muhammad Rishfi, Alex Whale, Neesha Kara, Simon R. Andrews, et al.